Juventix Regenerative Medical PRP Highlighted in University-Published Research Study
Washingtoner/10277008

TAMPA, Fla. - Washingtoner -- Juventix Regenerative Medical, a leader in regenerative medicine solutions, proudly announces that its Platelet-Rich Plasma (PRP) technology has been featured in a groundbreaking university-published research study. The study, titled "Platelet-Rich Plasma for Rheumatoid Arthritis: A Case Series", published in the peer-reviewed journal Cureus, underscores the efficacy of Juventix PRP in managing rheumatoid arthritis, showcasing its transformative potential in clinical applications.

The study explores the use of PRP to address inflammation and improve outcomes in rheumatoid arthritis patients, with findings demonstrating measurable benefits attributed to Juventix PRP's advanced process. The research highlights the role of PRP in promoting tissue repair and reducing joint pain, offering a promising non-surgical alternative for patients seeking regenerative therapies.

Scientific Validation Backed by Laboratory Studies
Juventix PRP's inclusion in this research aligns with findings from extensive laboratory evaluations conducted by BioSciences Research Associates (2020) and Biofyl Scientific Research (2023). Key results include:

• 84% platelet recovery, significantly enhancing platelet-derived growth factor (PDGF) concentrations.
• 10x increase in PDGF levels, with treated PRP reaching 10,844 pg/mL compared to 1,536 pg/mL in untreated samples.
• Minimal contamination of red and white blood cells, ensuring safety and reducing inflammatory risks.
• Optimized pH of 7.5, creating an ideal environment for platelet activation and growth factor release.
• Innovative activation methods, including photoactivation and bio-incubation, transforming PRP into PRF for versatile clinical applications.

"The inclusion of Juventix PRP in a peer-reviewed study underscores our commitment to delivering scientifically validated, high-quality regenerative solutions," said Lance Liberti, CEO of Juventix Regenerative Medical. "Our focus on innovation ensures practitioners can trust Juventix PRP for consistent, superior patient outcomes."

More on Washingtoner

• Spokane City Council Votes on Modification For 2026 City Budget
• Spokane: Council Approves New Transportation Tax on Commercial Parking
• Scoop Social Co.'s Mobile Dessert Truck Business Offer A Lifestyle Of Flavor, Fun, and Freedom
• Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
• Lakefront Acreage in Longwood's Ravensbrook Community Hits the Market

Special Offer for Medical Practitioners
To introduce clinicians to its cutting-edge PRP systems, Juventix is offering a sample PRP kit for only $20. This limited-time opportunity enables practitioners to experience the proven quality of Juventix PRP firsthand.
• Email: hello@juventix.com with the subject line "SAMPLE"
• Visit: https://juventix.com/sample-page/

About Juventix Regenerative Medical, LLC
Founded in 2017 by Lance Liberti, Juventix Regenerative Medical has been a pioneer in non-surgical regenerative solutions, including FDA-cleared PRP kits. The company offers comprehensive products such as centrifuges, LED activators, and bio-incubators to support superior PRP preparation. Juventix also collaborates with prestigious organizations, including the University of South Florida (USF) Health Center for Advanced Medical Learning and Simulation (CAMLS), to host advanced clinical training symposiums.

For more information, visit www.Juventix.com or contact:
📞 (866) 693-4777

More on Washingtoner

• Monika Balayan Elected Fellow of the Royal Society of Arts (FRSA)
• Spokane: Stuff Green Carts with Food and Yard Waste
• Fatal Early Morning House Fire in Northwest Spokane Claims Life of Chi
• We're Winning: Historic Plunge in Overdose Deaths Marks Stunning Reversal in America's Drug Crisis
• Tacoma: Applicants sought for the Human Rights Commission

✉️ Email: hello@juventix.com
Restore, Revive, Regenerate – Juventix Regenerative Medical.